This site uses cookies. By using this site you agree to receiving cookies. View Policy.

Successfully funded
Capital at risk
overfunded
Airmony
  • Equity
  • Spain Spain
106%
Raised
£212,480
Investors
187
Target
£200,000
Equity
6.46%
Pre-money valuation
£3,075,000

Airmony is a new sleep apnea device. Portable, light and tubeless, Airmony pushes a continuous flow of air to help sleep apnea patients breathe and enjoy a good night’s sleep. It includes sensors for e-health tech, allowing patients and their doctors to monitor sleep patterns.

  • Aiming to be the first tubeless device, portable & USB battery-powered
  • E-Health compatible for self-monitoring or to connect with your doctor
  • Approx 20m people diagnosed with sleep apnea across the U.S and Europe
  • Market growing at 7.8% CAGR – All competitors are tabletop

Idea

Obstructive Sleep Apnea (OSAS) is a common sleep disorder where breathing stops for a few seconds during sleep. It affects up to 6% of the world’s adult population; mostly men, but also women, children and even athletes. Untreated, moderate to severe OSAS can lead to serious health complications, such as heart disease, stroke, diabetes, cancer and depression.

Continuous Positive Airway Pressure (CPAP) devices exist to treat this condition, but our research suggests that 98% are clunky, intrusive, table top versions. Airmony is a new CPAP device – it’s smaller, lighter, tubeless, washable and can be used both by children and adults.

With its low noise level, Airmony is discreet but effective and it runs for more than two nights on a USB rechargeable battery. It also includes sensors for e-health monitoring, allowing both patients and their doctor to review sleep patterns.

Airmony’s development is supported by numerous institutions, including the Estivill Sleep Foundation, founded by renowned sleep specialist, Dr. Eduard Estivill.

We aim to operate with a hybrid model, through distributors and online direct sales, alongside our app, which is currently in development. The sleep apnea devices market is growing at a CAGR of 7.8%, and the total addressable market is projected to be worth $6.49bn by 2023.

THE MATERIALS YOU ARE SEEKING TO ACCESS ARE BEING MADE AVAILABLE BY THE COMPANY RAISING FINANCE AS IDENTIFIED ABOVE (THE "COMPANY") IN GOOD FAITH AND FOR INFORMATION PURPOSES ONLY AND SUBJECT TO THESE TERMS AND CONDITIONS.  CROWDCUBE CAPITAL LTD IS AUTHORISED BY THE FCA AND CARRIES OUT DUE DILIGENCE ON EACH COMPANY THAT LISTS ON CROWDCUBE AS SET OUT HERE.
 
This investment opportunity is not an offer to the public and is only available to registered members of Crowdcube.com who have qualified and categorised themselves as able to invest.  The investment opportunity is not directed at persons located in the United States, Canada or Japan. Any person resident outside the United Kingdom who wishes to view these materials must first satisfy themselves that they are not subject to any local requirements that prohibit or restrict access.
In particular, unless otherwise determined by the Company and permitted by applicable law and regulation, it is not intended, subject to certain exceptions, that any offering of the securities mentioned in such materials (the "Securities") by the Company would be made, or any documentation be sent in or into, the United States, Canada or Japan.  There will be no public offering of the Securities in the United States.
 
In order to access the pitch you must first become a qualifying member of Crowdcube on the basis of your status as either (i) self-certified ‘high net worth investor’, (ii) certified ‘sophisticated investor’, (iii) self-certified as a ‘sophisticated investor’ or (iv) certified as a ‘restricted investor’, in each case in accordance with the FCA’s Conduct of Business Sourcebook Chapter 4.7.  Potential investors are encouraged to "cross examine" the Company by interactive due diligence and use of the available online forums to bring the "wisdom of the crowd" to bear.  Accessing the pitch also means you agree to Crowdcube’s most recent website terms and conditions and investor terms and conditions, which include Crowdcube's limitation of liability.
 
If you are not permitted to view materials on this webpage or are in any doubt as to whether you are permitted to view these materials, please exit this webpage.  Crowdcube’s or the Issuer’s press announcements and this information page do not constitute an offer to sell securities of the Company.  Further, it does not constitute a recommendation by the Company, Crowdcube or any other party to sell or buy securities in the Company.
 
By registering or logging into Crowdcube.com to view the investment opportunity, you certify that you are legally entitled to view the investment opportunities, are an authorised investor and you agree to all applicable terms and conditions on this website, including this disclaimer.

To see the rest of the Airmony pitch, join now.
It’s free, quick and easy.

Join

Already registered? Log in

To see the rest of the Airmony pitch, join now.
It’s free, quick and easy.

Airmony

Join to read more information about the Airmony team, documents, and what other investors are saying about the pitch.

If you choose to invest we won’t take your money until the pitch closes and you can cancel your investment at any time.

Crowdcube is a leading investment crowdfunding platform

Successfully Invested
£689m+
Registered Investors
762k+